[Plasma changes caused by estrogens in the vascular risk of prostatic carcinoma over a 3-year period].
D000368:Aged; D000369:Aged, 80 and over; D002784:Cholesterol / Q000097:blood; D004054:Diethylstilbestrol / Q000627:therapeutic use*; D004961:Estramustine / Q000627:therapeutic use*; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000097:blood* / Q000188:drug therapy; D011897:Random Allocation; D014280:Triglycerides / Q000097:blood
D009588:Nitrogen Mustard Compounds; D014280:Triglycerides; D004961:Estramustine; D004054:Diethylstilbestrol; D005340:Fibrinogen; D002784:Cholesterol
Los cambios plasmáticos por estrogenización en el riesgo vascular del carcinoma prostático a través de tres años.